| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 7.91e-05 | 27 | 62 | 3 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 8.84e-05 | 28 | 62 | 3 | GO:0099602 | |
| GeneOntologyMolecularFunction | retromer complex binding | 4.20e-04 | 10 | 62 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.47e-04 | 206 | 62 | 5 | GO:0140030 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 4.83e-05 | 225 | 60 | 6 | GO:0030705 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 5.14e-05 | 25 | 60 | 3 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 7.28e-05 | 28 | 60 | 3 | GO:1904031 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 9.23e-05 | 253 | 60 | 6 | GO:0099111 | |
| Domain | FAM21 | 1.01e-05 | 2 | 60 | 2 | IPR027308 | |
| Domain | FAM21/CAPZIP | 3.04e-05 | 3 | 60 | 2 | IPR029341 | |
| Domain | CAP-ZIP_m | 3.04e-05 | 3 | 60 | 2 | PF15255 | |
| Domain | CH | 8.88e-05 | 73 | 60 | 4 | PS50021 | |
| Domain | CH-domain | 9.86e-05 | 75 | 60 | 4 | IPR001715 | |
| Domain | Spy1 | 5.48e-04 | 11 | 60 | 2 | PF11357 | |
| Domain | Speedy | 5.48e-04 | 11 | 60 | 2 | IPR020984 | |
| Domain | CH | 1.48e-03 | 70 | 60 | 3 | PF00307 | |
| Domain | Actinin_actin-bd_CS | 2.46e-03 | 23 | 60 | 2 | IPR001589 | |
| Domain | Spectrin | 2.46e-03 | 23 | 60 | 2 | PF00435 | |
| Domain | ACTININ_2 | 2.46e-03 | 23 | 60 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.46e-03 | 23 | 60 | 2 | PS00019 | |
| Domain | ZnF_U1 | 3.90e-03 | 29 | 60 | 2 | SM00451 | |
| Domain | Znf_U1 | 3.90e-03 | 29 | 60 | 2 | IPR003604 | |
| Domain | FYVE | 3.90e-03 | 29 | 60 | 2 | PF01363 | |
| Domain | FYVE | 3.90e-03 | 29 | 60 | 2 | SM00064 | |
| Domain | Spectrin_repeat | 3.90e-03 | 29 | 60 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 4.73e-03 | 32 | 60 | 2 | IPR018159 | |
| Domain | SPEC | 4.73e-03 | 32 | 60 | 2 | SM00150 | |
| Domain | Death | 5.03e-03 | 33 | 60 | 2 | PF00531 | |
| Domain | Znf_FYVE-rel | 5.33e-03 | 34 | 60 | 2 | IPR017455 | |
| Domain | FHA_dom | 5.96e-03 | 36 | 60 | 2 | IPR000253 | |
| Domain | - | 5.96e-03 | 36 | 60 | 2 | 2.60.200.20 | |
| Domain | Death_domain | 6.62e-03 | 38 | 60 | 2 | IPR000488 | |
| Domain | Znf_FYVE | 6.62e-03 | 38 | 60 | 2 | IPR000306 | |
| Domain | DEATH_DOMAIN | 6.62e-03 | 38 | 60 | 2 | PS50017 | |
| Domain | ZF_FYVE | 7.32e-03 | 40 | 60 | 2 | PS50178 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RABL6 ILF3 WASHC2C ATRX MATR3 CAMSAP3 BOP1 WASHC2A HSPA4 TP53BP1 DMXL1 | 7.47e-10 | 475 | 62 | 11 | 31040226 |
| Pubmed | NOL4L IKZF3 DST ATRX ATF7IP MATR3 SYNE2 TAF1 EIF3D WASHC2A ZBTB1 HSPA4 DYNC1H1 TP53BP1 DDX10 | 2.25e-08 | 1429 | 62 | 15 | 35140242 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ILF3 DST WASHC2C ANK2 ATRX ATF7IP MATR3 NASP EIF3D HSPA4 TP53BP1 DDX10 | 8.25e-08 | 934 | 62 | 12 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOL4L ILF3 WASHC2C LEO1 ATRX ZC3H13 MATR3 CAMSAP3 NASP TP53BP1 LRRFIP1 | 1.12e-07 | 774 | 62 | 11 | 15302935 |
| Pubmed | KIF13B ILF3 DST ANK2 ATF7IP MATR3 SYNE2 CAMSAP3 ZBTB1 DYNC1H1 TP53BP1 LRRFIP1 | 1.15e-07 | 963 | 62 | 12 | 28671696 | |
| Pubmed | KIF13B ILF3 DST ANK2 LEO1 ATRX SPEF2 MATR3 DZIP1L SYNE2 CAMSAP3 DNAJC21 ANKRD30B DTHD1 | 1.87e-07 | 1442 | 62 | 14 | 35575683 | |
| Pubmed | 2.65e-07 | 503 | 62 | 9 | 16964243 | ||
| Pubmed | KIF13B NOL4L WASHC2C ATRX ZC3H13 MATR3 DZIP1L NASP BOP1 NCOA4 WASHC2A TP53BP1 | 4.06e-07 | 1084 | 62 | 12 | 11544199 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 4.50e-07 | 9 | 62 | 3 | 36272447 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 6.67e-07 | 92 | 62 | 5 | 15840729 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B IKZF3 MIS18BP1 WASHC2C LEO1 ATRX ATF7IP WASHC2A TP53BP1 | 9.71e-07 | 588 | 62 | 9 | 38580884 |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 1.52e-06 | 13 | 62 | 3 | 15611625 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.72e-06 | 203 | 62 | 6 | 22083510 | |
| Pubmed | 2.29e-06 | 653 | 62 | 9 | 22586326 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ILF3 LEO1 ZC3H13 MATR3 NASP EIF3D SUCLG2 HSPA4 DYNC1H1 LRRFIP1 | 2.38e-06 | 847 | 62 | 10 | 35235311 |
| Pubmed | DST ANK2 LEO1 ATRX ZNF532 ADAMTS9 APBA1 NASP TAF1 EIF3D DYNC1H1 LRRFIP1 | 2.40e-06 | 1285 | 62 | 12 | 35914814 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 33468623 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 20827171 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12087094 | ||
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 3.13e-06 | 2 | 62 | 2 | 36717248 | |
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 3.13e-06 | 2 | 62 | 2 | 16496311 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 15847701 | ||
| Pubmed | Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X. | 3.13e-06 | 2 | 62 | 2 | 16465597 | |
| Pubmed | Cloning and characterization of the 5'-flanking region of the Ehox gene. | 3.13e-06 | 2 | 62 | 2 | 16414020 | |
| Pubmed | 3.23e-06 | 506 | 62 | 8 | 30890647 | ||
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 3.60e-06 | 17 | 62 | 3 | 15574121 | |
| Pubmed | 5.83e-06 | 251 | 62 | 6 | 29778605 | ||
| Pubmed | 6.45e-06 | 67 | 62 | 4 | 29254152 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 6.49e-06 | 949 | 62 | 10 | 36574265 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.94e-06 | 148 | 62 | 5 | 32538781 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 18077458 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 18562707 | ||
| Pubmed | Factors determining DNA double-strand break repair pathway choice in G2 phase. | 9.37e-06 | 3 | 62 | 2 | 21317870 | |
| Pubmed | 9.59e-06 | 418 | 62 | 7 | 34709266 | ||
| Pubmed | ILF3 ANK2 ATRX ZC3H13 SYNE2 DNAJC21 BOP1 WASHC2A HSPA4 TP53BP1 DMXL1 DDX10 | 1.06e-05 | 1487 | 62 | 12 | 33957083 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.15e-05 | 283 | 62 | 6 | 30585729 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 1.18e-05 | 165 | 62 | 5 | 16107646 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.34e-05 | 440 | 62 | 7 | 34244565 | |
| Pubmed | 1.35e-05 | 441 | 62 | 7 | 31239290 | ||
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 1.71e-05 | 28 | 62 | 3 | 26812015 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.74e-05 | 179 | 62 | 5 | 36261009 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 15707895 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RABL6 ILF3 ZC3H13 MATR3 NASP BOP1 EIF3D SUCLG2 HSPA4 DYNC1H1 DDX10 | 1.91e-05 | 1318 | 62 | 11 | 30463901 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.24e-05 | 477 | 62 | 7 | 31300519 | |
| Pubmed | STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1. | 2.34e-05 | 31 | 62 | 3 | 28089446 | |
| Pubmed | 2.38e-05 | 191 | 62 | 5 | 20195357 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 ILF3 DST MATR3 BOP1 EIF3D SUCLG2 HSPA4 DYNC1H1 TP53BP1 DDX10 | 2.43e-05 | 1353 | 62 | 11 | 29467282 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.76e-05 | 197 | 62 | 5 | 20811636 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.84e-05 | 332 | 62 | 6 | 32786267 | |
| Pubmed | Expression of a novel homeobox gene Ehox in trophoblast stem cells and pharyngeal pouch endoderm. | 3.12e-05 | 5 | 62 | 2 | 14648851 | |
| Pubmed | Targeted loss of the ATR-X syndrome protein in the limb mesenchyme of mice causes brachydactyly. | 3.12e-05 | 5 | 62 | 2 | 23892236 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 26022179 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 4.26e-05 | 724 | 62 | 8 | 36232890 | |
| Pubmed | 4.35e-05 | 38 | 62 | 3 | 28680062 | ||
| Pubmed | 4.45e-05 | 360 | 62 | 6 | 33111431 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.78e-05 | 736 | 62 | 8 | 29676528 | |
| Pubmed | 4.81e-05 | 538 | 62 | 7 | 28524877 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 6.16e-05 | 989 | 62 | 9 | 36424410 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 6.44e-05 | 120 | 62 | 4 | 31413325 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ILF3 DST ZC3H13 MATR3 DNAJC21 BOP1 ABT1 EIF3D DYNC1H1 LRRFIP1 | 7.14e-05 | 1257 | 62 | 10 | 36526897 |
| Pubmed | 7.45e-05 | 1014 | 62 | 9 | 32416067 | ||
| Pubmed | 7.64e-05 | 397 | 62 | 6 | 21319273 | ||
| Pubmed | 7.85e-05 | 399 | 62 | 6 | 35987950 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.03e-05 | 1024 | 62 | 9 | 24711643 | |
| Pubmed | A FAM21-containing WASH complex regulates retromer-dependent sorting. | 8.69e-05 | 8 | 62 | 2 | 19922874 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 9.55e-05 | 256 | 62 | 5 | 32698014 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.00e-04 | 605 | 62 | 7 | 28977666 | |
| Pubmed | 1.03e-04 | 419 | 62 | 6 | 15635413 | ||
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 1.12e-04 | 9 | 62 | 2 | 7874112 | |
| Pubmed | Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. | 1.39e-04 | 10 | 62 | 2 | 19826009 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 21972064 | ||
| Pubmed | 1.45e-04 | 148 | 62 | 4 | 35676246 | ||
| Pubmed | 1.57e-04 | 151 | 62 | 4 | 17043677 | ||
| Pubmed | Y chromosome damage underlies testicular abnormalities in ATR-X syndrome. | 1.70e-04 | 11 | 62 | 2 | 38616920 | |
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 1.70e-04 | 11 | 62 | 2 | 37142680 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.79e-04 | 665 | 62 | 7 | 30457570 | |
| Pubmed | 1.89e-04 | 469 | 62 | 6 | 37314180 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.99e-04 | 1155 | 62 | 9 | 20360068 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 23011808 | ||
| Pubmed | The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex. | 2.04e-04 | 12 | 62 | 2 | 19922875 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 19486527 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 29500366 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 27390154 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RABL6 LEO1 COG7 NASP BOP1 EIF3D WASHC2A HSPA4 DYNC1H1 LRRFIP1 | 2.35e-04 | 1455 | 62 | 10 | 22863883 |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 14690447 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 2.41e-04 | 169 | 62 | 4 | 23084401 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 2.54e-04 | 316 | 62 | 5 | 31665637 | |
| Pubmed | 2.58e-04 | 497 | 62 | 6 | 23414517 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 2.75e-04 | 175 | 62 | 4 | 25756610 | |
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 2.81e-04 | 14 | 62 | 2 | 10976766 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.84e-04 | 954 | 62 | 8 | 36373674 | |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 3.07e-04 | 73 | 62 | 3 | 32347575 | |
| Pubmed | 3.10e-04 | 330 | 62 | 5 | 32529326 | ||
| Pubmed | 3.18e-04 | 731 | 62 | 7 | 29298432 | ||
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 3.19e-04 | 182 | 62 | 4 | 26527279 | |
| Pubmed | 3.20e-04 | 74 | 62 | 3 | 33989516 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 3.23e-04 | 333 | 62 | 5 | 32665550 | |
| Pubmed | Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling. | 3.23e-04 | 15 | 62 | 2 | 28892079 | |
| Pubmed | 3.32e-04 | 75 | 62 | 3 | 29459360 | ||
| Pubmed | 3.54e-04 | 187 | 62 | 4 | 26460568 | ||
| Interaction | HDAC4 interactions | RABL6 KIF13B IKZF3 ILF3 WASHC2C ATRX MATR3 CAMSAP3 BOP1 TP53BP1 DMXL1 | 1.25e-05 | 744 | 61 | 11 | int:HDAC4 |
| Interaction | RAD50 interactions | 1.54e-05 | 371 | 61 | 8 | int:RAD50 | |
| Interaction | CHD4 interactions | RABL6 NOL4L IKZF3 ILF3 LEO1 MATR3 NAB1 NASP BOP1 EIF3D LRRFIP1 DDX10 | 2.04e-05 | 938 | 61 | 12 | int:CHD4 |
| Interaction | SPDYE3 interactions | 2.70e-05 | 3 | 61 | 2 | int:SPDYE3 | |
| Interaction | NAA40 interactions | ILF3 DST WASHC2C ANK2 ATRX ATF7IP MATR3 NASP EIF3D HSPA4 TP53BP1 DDX10 | 3.07e-05 | 978 | 61 | 12 | int:NAA40 |
| Interaction | MEN1 interactions | KIF13B ILF3 WASHC2C ATRX ZC3H13 MATR3 BOP1 ABT1 TAF1 HSPA4 TP53BP1 DDX10 | 5.04e-05 | 1029 | 61 | 12 | int:MEN1 |
| Interaction | TRIM33 interactions | 6.35e-05 | 453 | 61 | 8 | int:TRIM33 | |
| Interaction | TERF2 interactions | 7.30e-05 | 340 | 61 | 7 | int:TERF2 | |
| Interaction | ACTB interactions | ILF3 DST WASHC2C LEO1 COG7 ATF7IP MATR3 WASHC2A ZBTB1 HSPA4 DYNC1H1 LRRFIP1 | 8.24e-05 | 1083 | 61 | 12 | int:ACTB |
| Interaction | SIRT6 interactions | 1.07e-04 | 628 | 61 | 9 | int:SIRT6 | |
| Interaction | PIPSL interactions | 1.12e-04 | 252 | 61 | 6 | int:PIPSL | |
| Interaction | RCOR1 interactions | 1.16e-04 | 494 | 61 | 8 | int:RCOR1 | |
| Interaction | DCTN1 interactions | 1.21e-04 | 497 | 61 | 8 | int:DCTN1 | |
| Interaction | HERC2 interactions | 1.31e-04 | 503 | 61 | 8 | int:HERC2 | |
| Cytoband | 3p14.1 | 4.86e-04 | 24 | 62 | 2 | 3p14.1 | |
| Cytoband | 5p13.2 | 8.14e-04 | 31 | 62 | 2 | 5p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 2.14e-03 | 188 | 62 | 3 | chr10q11 | |
| Cytoband | Xq24 | 3.43e-03 | 64 | 62 | 2 | Xq24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq24 | 5.43e-03 | 81 | 62 | 2 | chrXq24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 5.95e-03 | 271 | 62 | 3 | chr7q11 | |
| Cytoband | 7q11.23 | 7.69e-03 | 97 | 62 | 2 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 7.72e-03 | 298 | 62 | 3 | chr5q31 | |
| GeneFamily | WASH complex | 7.86e-05 | 6 | 42 | 2 | 1331 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 3.43e-04 | 12 | 42 | 2 | 756 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 2.35e-03 | 31 | 42 | 2 | 81 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.37e-06 | 90 | 62 | 5 | M39250 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 2.79e-08 | 67 | 58 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.77e-07 | 151 | 58 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 2.60e-07 | 97 | 58 | 6 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 4.27e-07 | 23 | 58 | 4 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 4.30e-07 | 172 | 58 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 4.65e-07 | 107 | 58 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 7.16e-07 | 26 | 58 | 4 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 8.79e-07 | 382 | 58 | 9 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 9.02e-07 | 192 | 58 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | MIS18BP1 ATRX ADAMTS9 COG7 CLTRN ZC3H13 SYNE2 CAMSAP3 NASP DNAJC21 DMXL1 DDX10 | 9.13e-07 | 770 | 58 | 12 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 9.79e-07 | 387 | 58 | 9 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | MIS18BP1 ATRX ADAMTS9 COG7 STK17B CLTRN ZC3H13 SYNE2 NASP DNAJC21 DMXL1 DDX10 | 9.91e-07 | 776 | 58 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_100 | 3.14e-06 | 11 | 58 | 3 | gudmap_developingGonad_e14.5_ epididymis_100_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 4.71e-06 | 159 | 58 | 6 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | RABL6 MIS18BP1 ANK2 LEO1 ATRX RELL2 ZC3H13 SYNE2 NASP DNAJC21 HSPA4 PIF1 TP53BP1 DDX10 | 5.25e-06 | 1257 | 58 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 6.24e-06 | 167 | 58 | 6 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 8.27e-06 | 101 | 58 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATRX ADAMTS9 COG7 CLTRN ZC3H13 SYNE2 NASP DNAJC21 NCOA4 DMXL1 DDX10 | 8.62e-06 | 795 | 58 | 11 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | MIS18BP1 ATRX ADAMTS9 COG7 CLTRN ZC3H13 MATR3 SYNE2 NASP NCOA4 DMXL1 | 9.58e-06 | 804 | 58 | 11 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MIS18BP1 ATRX ADAMTS9 COG7 CLTRN ZC3H13 MATR3 SYNE2 NASP DMXL1 DDX10 | 9.81e-06 | 806 | 58 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CACNA1F MIS18BP1 ATRX SYNE2 CAMSAP3 NASP TAF1 NCOA4 FGD6 ZBTB1 HSPA4 PIF1 | 1.20e-05 | 989 | 58 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.38e-05 | 192 | 58 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.40e-05 | 291 | 58 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 1.46e-05 | 409 | 58 | 8 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_200 | 1.53e-05 | 18 | 58 | 3 | gudmap_developingGonad_P2_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.68e-05 | 417 | 58 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.14e-05 | 311 | 58 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.16e-05 | 432 | 58 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.30e-05 | 210 | 58 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 2.33e-05 | 61 | 58 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_200 | 2.48e-05 | 21 | 58 | 3 | gudmap_developingGonad_e14.5_ epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.73e-05 | 323 | 58 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RABL6 MIS18BP1 ANK2 LEO1 ATRX RELL2 ZC3H13 SYNE2 NASP DNAJC21 HSPA4 PIF1 TP53BP1 DDX10 | 2.84e-05 | 1459 | 58 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 3.00e-05 | 65 | 58 | 4 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.14e-05 | 595 | 58 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.38e-05 | 225 | 58 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_100 | 3.58e-05 | 68 | 58 | 4 | gudmap_developingGonad_e12.5_ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 3.79e-05 | 69 | 58 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.83e-05 | 230 | 58 | 6 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | ATRX ADAMTS9 COG7 CLTRN ZC3H13 SYNE2 NASP DNAJC21 DMXL1 DDX10 | 4.36e-05 | 778 | 58 | 10 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | MIS18BP1 ATRX ADAMTS9 COG7 CLTRN ZC3H13 MATR3 SYNE2 NASP DMXL1 | 5.34e-05 | 797 | 58 | 10 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 5.44e-05 | 492 | 58 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 5.58e-05 | 150 | 58 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 5.92e-05 | 498 | 58 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | RABL6 MIS18BP1 ATRX ADAMTS9 MATR3 SYNE2 NASP NCOA4 SDC2 DMXL1 | 6.71e-05 | 819 | 58 | 10 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 7.80e-05 | 161 | 58 | 5 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 7.80e-05 | 161 | 58 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 8.22e-05 | 84 | 58 | 4 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 9.01e-05 | 166 | 58 | 5 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 9.01e-05 | 166 | 58 | 5 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.03e-04 | 275 | 58 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.07e-04 | 90 | 58 | 4 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.10e-04 | 403 | 58 | 7 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.12e-04 | 404 | 58 | 7 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.15e-04 | 406 | 58 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.28e-04 | 413 | 58 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_500 | 1.30e-04 | 36 | 58 | 3 | gudmap_developingGonad_P2_epididymis_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.40e-04 | 564 | 58 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.44e-04 | 97 | 58 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.59e-04 | 298 | 58 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 2.25e-04 | 109 | 58 | 4 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 2.53e-04 | 45 | 58 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_200 | 2.53e-04 | 45 | 58 | 3 | gudmap_developingGonad_e14.5_ ovary_200_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CELSR1 MIS18BP1 ANK2 ATRX ZC3H13 SYNE2 NASP DNAJC21 RALGAPA2 HSPA4 PIF1 TP53BP1 | 2.76e-04 | 1370 | 58 | 12 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.94e-04 | 799 | 58 | 9 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.94e-04 | 629 | 58 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 3.00e-04 | 801 | 58 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | MIS18BP1 ATRX COG7 SYNE2 NASP NCOA4 RALGAPA2 FGD6 HSPA4 PIF1 | 3.03e-04 | 985 | 58 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_100 | 3.25e-04 | 10 | 58 | 2 | gudmap_developingGonad_e18.5_ovary_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 3.41e-04 | 815 | 58 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.03e-04 | 127 | 58 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.26e-04 | 232 | 58 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | MIS18BP1 ANK2 ATRX ZC3H13 SYNE2 NASP DNAJC21 HSPA4 PIF1 TP53BP1 | 5.40e-04 | 1060 | 58 | 10 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.52e-04 | 138 | 58 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 5.75e-04 | 379 | 58 | 6 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.75e-04 | 379 | 58 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 6.24e-04 | 385 | 58 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 6.42e-04 | 387 | 58 | 6 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 7.00e-04 | 147 | 58 | 4 | gudmap_developingGonad_e18.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.03e-04 | 259 | 58 | 5 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 7.14e-04 | 395 | 58 | 6 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 7.49e-04 | 65 | 58 | 3 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_100 | 7.53e-04 | 15 | 58 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 7.93e-04 | 152 | 58 | 4 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 8.23e-04 | 406 | 58 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 8.74e-04 | 156 | 58 | 4 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200 | 8.95e-04 | 157 | 58 | 4 | gudmap_developingGonad_P2_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.49e-04 | 277 | 58 | 5 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | KIF13B NOL4L CELSR1 FAM174A ADAMTS9 CLTRN CAMSAP3 NCOA4 FGD6 LRRFIP1 | 1.03e-03 | 1153 | 58 | 10 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.21e-03 | 780 | 58 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_200 | 1.22e-03 | 19 | 58 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.31e-03 | 790 | 58 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_100 | 1.32e-03 | 79 | 58 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 1.36e-03 | 989 | 58 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_100 | 1.52e-03 | 83 | 58 | 3 | gudmap_developingGonad_e18.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_100 | 1.64e-03 | 22 | 58 | 2 | gudmap_developingGonad_e16.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 1.65e-03 | 819 | 58 | 8 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | 1.66e-03 | 820 | 58 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.67e-03 | 186 | 58 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100 | 1.69e-03 | 86 | 58 | 3 | gudmap_developingGonad_e16.5_epididymis_100 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 9.44e-09 | 199 | 60 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.93e-07 | 200 | 60 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19_Mild-PLT_5|World / Disease Group and Platelet Clusters | 1.94e-06 | 152 | 60 | 5 | 90ba4e8a735ec8921038fa072129535f0e3fd9ae | |
| ToppCell | ILEUM-inflamed-(1)_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.33e-06 | 187 | 60 | 5 | a77d7ae44f47410bd92fb3aa0f44dce891752b63 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.47e-06 | 188 | 60 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.62e-06 | 189 | 60 | 5 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.06e-06 | 192 | 60 | 5 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-06 | 198 | 60 | 5 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 7.22e-06 | 199 | 60 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 7.22e-06 | 199 | 60 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 7.22e-06 | 199 | 60 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.39e-06 | 200 | 60 | 5 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.39e-06 | 200 | 60 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.39e-06 | 200 | 60 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.39e-06 | 200 | 60 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.62e-05 | 138 | 60 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.25e-05 | 165 | 60 | 4 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.25e-05 | 165 | 60 | 4 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 7.77e-05 | 168 | 60 | 4 | d50078614f7af74dc2aa4081c1708a5156ac51cf | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 8.90e-05 | 174 | 60 | 4 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.30e-05 | 176 | 60 | 4 | 856a8c4211ea33d926b18d8959a03909562aa563 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-05 | 176 | 60 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.01e-04 | 180 | 60 | 4 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 181 | 60 | 4 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 1.04e-04 | 181 | 60 | 4 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.06e-04 | 182 | 60 | 4 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.08e-04 | 183 | 60 | 4 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.08e-04 | 183 | 60 | 4 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.08e-04 | 183 | 60 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 184 | 60 | 4 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 185 | 60 | 4 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 1.13e-04 | 185 | 60 | 4 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 185 | 60 | 4 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 186 | 60 | 4 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 186 | 60 | 4 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 186 | 60 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 186 | 60 | 4 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.15e-04 | 186 | 60 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 187 | 60 | 4 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 1.20e-04 | 188 | 60 | 4 | 21730497f95dc271e4cdfaaf1da8b9ac6eec2ded | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.22e-04 | 189 | 60 | 4 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 1.22e-04 | 189 | 60 | 4 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.22e-04 | 189 | 60 | 4 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.22e-04 | 189 | 60 | 4 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Trm/em_CD8|Lung / Manually curated celltypes from each tissue | 1.25e-04 | 190 | 60 | 4 | 74638e470ece8016465bbebc1756ffa6d605b25f | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 1.25e-04 | 190 | 60 | 4 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.27e-04 | 191 | 60 | 4 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.27e-04 | 191 | 60 | 4 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.27e-04 | 191 | 60 | 4 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.30e-04 | 192 | 60 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-04 | 192 | 60 | 4 | 97c312c82ec025c13052f8d424b11c0034c8ea54 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.30e-04 | 192 | 60 | 4 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-04 | 192 | 60 | 4 | 3b0a52e4e77ae4539a034dcb419773b8e2aa5d51 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 1.33e-04 | 193 | 60 | 4 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-NK|Bac-SEP / Disease, Lineage and Cell Type | 1.33e-04 | 193 | 60 | 4 | 8aa4ed2b11c6189d86e7de6bc68782fd156a37fb | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 1.33e-04 | 193 | 60 | 4 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 193 | 60 | 4 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 193 | 60 | 4 | 523e2541f9f8d22b3c5263839a57cc1ab23d4963 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 60 | 4 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 60 | 4 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | COVID-19_Severe-CD8+_Tem|World / disease group, cell group and cell class | 1.35e-04 | 194 | 60 | 4 | 60aa16e166894e3fcd82f7a54607c2c02e55b614 | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 60 | 4 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 1.38e-04 | 195 | 60 | 4 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.38e-04 | 195 | 60 | 4 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-04 | 195 | 60 | 4 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-04 | 195 | 60 | 4 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 1.38e-04 | 195 | 60 | 4 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.38e-04 | 195 | 60 | 4 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-04 | 196 | 60 | 4 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.41e-04 | 196 | 60 | 4 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / disease group, cell group and cell class | 1.41e-04 | 196 | 60 | 4 | 1bc1ec3351319c5d2daa0808cf161a7327e1758e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 197 | 60 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.44e-04 | 197 | 60 | 4 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 197 | 60 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.44e-04 | 197 | 60 | 4 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-04 | 198 | 60 | 4 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.46e-04 | 198 | 60 | 4 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.46e-04 | 198 | 60 | 4 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.46e-04 | 198 | 60 | 4 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.46e-04 | 198 | 60 | 4 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-04 | 198 | 60 | 4 | 06b1f14d428d816dc471c21faa91993f8fb701e2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-04 | 198 | 60 | 4 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.46e-04 | 198 | 60 | 4 | 2977e16a8dc92d69b6ed184316136f7f740fb4fd | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.46e-04 | 198 | 60 | 4 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.46e-04 | 198 | 60 | 4 | b718abbd7c2706866d191fb54f27ce5f594c34a6 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.46e-04 | 198 | 60 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-04 | 198 | 60 | 4 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 1.46e-04 | 198 | 60 | 4 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 199 | 60 | 4 | 8b524d5fdece8fbeb8889da3f86da7f20e646fff | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 199 | 60 | 4 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.49e-04 | 199 | 60 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 199 | 60 | 4 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.49e-04 | 199 | 60 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.49e-04 | 199 | 60 | 4 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 199 | 60 | 4 | b051e3890bec7b8c6dc36ea433b53b9297839783 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.16e-07 | 49 | 38 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.72e-05 | 50 | 38 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Disease | biliary liver cirrhosis | 8.11e-05 | 44 | 56 | 3 | EFO_0004267 | |
| Disease | FEV/FEC ratio | 9.34e-05 | 1228 | 56 | 10 | EFO_0004713 | |
| Disease | forced expiratory volume | 1.15e-04 | 789 | 56 | 8 | EFO_0004314 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.97e-04 | 75 | 56 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | longevity, healthspan, parental longevity | 1.39e-03 | 29 | 56 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | cesarean section, Self-injurious behavior | 1.69e-03 | 32 | 56 | 2 | EFO_0009636, HP_0100716 | |
| Disease | eosinophil count | 1.83e-03 | 1488 | 56 | 9 | EFO_0004842 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDELDQFLDKMDDPD | 166 | Q14137 | |
| EQGDELPELDNMADN | 666 | P83436 | |
| AQMFPSESKQKDDEE | 711 | Q9BXX2 | |
| DINDNAPMFEKDELE | 991 | Q9NYQ6 | |
| DEDKPEDEMAQKRAS | 891 | Q9P1Y5 | |
| DNDEENEDVPISMKE | 1971 | Q9Y485 | |
| EMEKEADQEDPQLCN | 666 | Q5U651 | |
| MENDPQEAESEMALD | 116 | Q3YEC7 | |
| KMNEDTQEEPGKSEE | 2721 | Q01484 | |
| SPEEEMEDSQDEQHK | 426 | Q8IYY4 | |
| AEELDMEDPSADDNL | 411 | O60840 | |
| DDEKMQNTDDEERPQ | 181 | Q8WVC0 | |
| EKDTKDDQTEQEPNM | 636 | P43243 | |
| QDSEDDDDILPNMDK | 1006 | Q6P0N0 | |
| NEEPMETDQNAKEEE | 506 | P34932 | |
| FEMNDDDPHKEEEIR | 236 | Q13506 | |
| QQMPEDKEDESEIEE | 2331 | Q03001 | |
| DKAKDRDPEMENEEQ | 791 | Q9BZQ6 | |
| LDDNSEEEMEDAPKQ | 366 | Q5F1R6 | |
| EDNDKMNDSEGMDPE | 171 | Q96MY1 | |
| FMEEPDRKDVAQEDA | 441 | Q2PPJ7 | |
| EEDDKENDKTEEMPN | 481 | P49321 | |
| ENDKTEEMPNDSVLE | 486 | P49321 | |
| EKVGDQELPDQDEMD | 286 | Q13772 | |
| DNFEDEEAMESDPAA | 71 | Q9Y2Y8 | |
| MEAEESEKAATEQEP | 1 | Q9ULW3 | |
| DDDDNDPENRIAKKM | 1261 | P46100 | |
| MDEQEDEEEQNKPHI | 191 | Q9P2N4 | |
| NPFVEDDMDKNEIAS | 341 | O15371 | |
| ESDNMDVPPEDDSKE | 61 | Q12906 | |
| LDKAAEDMPEAEQDL | 286 | Q02410 | |
| MFPDNAENEDDKQIE | 86 | Q6ZMT9 | |
| DETNPDLEEKMESSF | 461 | Q6VMQ6 | |
| EDKAEVDMDTDAPQV | 931 | Q14204 | |
| PQMQKSAIKDAEEDD | 701 | Q13206 | |
| PANEDEDIGDDSMKV | 46 | Q9UKT9 | |
| DSERKMDPAEEDTNV | 116 | P34741 | |
| DMKEPDEEKSDQQGE | 546 | Q32MZ4 | |
| LKSPLNDMSDDDDDD | 231 | Q9H8W4 | |
| MELTPLEQDDEDDDN | 166 | Q8TBP5 | |
| AEREDEDQDPSMKNE | 551 | Q9NQT8 | |
| DDDEAASDQENMDPI | 626 | Q9H611 | |
| DAQLQPPEDDDMNED | 56 | Q8NC24 | |
| KDEEIPENANNEKMS | 1706 | Q9C093 | |
| DEKEASENETDMEDP | 6356 | Q8WXH0 | |
| PEEENEEDFQMKIDD | 911 | P21675 | |
| DREDKENIPEDSSMV | 336 | O94768 | |
| SPAVDDEKELQDMNA | 16 | P0C7M4 | |
| PSEVDDAEDKCENMI | 176 | Q9HBJ8 | |
| MDDKSENEPIENEAA | 276 | Q96I99 | |
| PDLKEMTDATNEEET | 1116 | Q9HCE3 | |
| NDMEEDDEDPKQNIF | 216 | A6NNV3 | |
| NDMEEDDEDPKQNIF | 256 | P0DV79 | |
| LANDMEEDDEAPKQK | 451 | A6NKU9 | |
| ANDMEEDDEDPKQNI | 111 | Q495Y7 | |
| DPLEDKQDEDNGMKS | 856 | Q6ZV73 | |
| LSLFDEEEDKMEDQN | 801 | Q9Y4E1 | |
| SPAVDDEKELQDMNA | 16 | Q9BQY4 | |
| PCESQGEELKEENME | 671 | Q12888 | |
| EKMDLEENPDEQSEI | 486 | Q9Y2K1 | |
| LSLFDEEEDKMEDQN | 801 | Q641Q2 | |
| NDMEEDDEDPKQNIF | 216 | A6NJR5 | |
| DAEKREDQQDEEKMP | 1476 | Q5T200 | |
| EDQQDEEKMPDPLDV | 1481 | Q5T200 | |
| NFNDEEEDELMMPSD | 2071 | Q9Y493 |